Abstract:Cellular senescence is a form of proliferative arrest triggered in response to a wide variety of stimuli and characterized by unique changes in cell morphology and function. Although unable to divide, senescent cells remain metabolically active and acquire the ability to produce and secrete bioactive molecules, some of which have recognized pro-inflammatory and/or pro-tumorigenic actions. As expected, this “senescence-associated secretory phenotype (SASP)” accounts for most of the non-cell-autonomous effects of senescent cells, which can be beneficial or detrimental for tissue homeostasis, depending on the context. It is now evident that many features linked to cellular senescence, including the SASP, reflect complex changes in the activities of mTOR and other metabolic pathways. Indeed, the available evidence indicates that mTOR-dependent signaling is required for the maintenance or implementation of different aspects of cellular senescence. Thus, depending on the cell type and biological context, inhibiting mTOR in cells undergoing senescence can reverse senescence, induce quiescence or cell death, or exacerbate some features of senescent cells while inhibiting others. Interestingly, autophagy—a highly regulated catabolic process—is also commonly upregulated in senescent cells. As mTOR activation leads to repression of autophagy in non-senescent cells (mTOR as an upstream regulator of autophagy), the upregulation of autophagy observed in senescent cells must take place in an mTOR-independent manner. Notably, there is evidence that autophagy provides free amino acids that feed the mTOR complex 1 (mTORC1), which in turn is required to initiate the synthesis of SASP components. Therefore, mTOR activation can follow the induction of autophagy in senescent cells (mTOR as a downstream effector of autophagy). These functional connections suggest the existence of autophagy regulatory pathways in senescent cells that differ from those activated in non-senescence contexts. We envision that untangling these functional connections will be key for the generation of combinatorial anti-cancer therapies involving pro-senescence drugs, mTOR inhibitors, and/or autophagy inhibitors.

Autophagy in Premature Senescent Cells is Activated Via AMPK Pathway

AMPK Activation Protects Cells from Oxidative Stress‐induced Senescence Via Autophagic Flux Restoration and Intracellular NAD + Elevation

Alginate Oligosaccharides Enhance Autophagy to Rejuvenate H2O2-Induced Senescent IEC-6 Through the AMPK/mTOR Signaling Pathway.

Autophagy Protects Premature Senescent 2BS Cells Induced by Hydrogen Peroxide from Apoptosis

Increased Amp : Atp Ratio And Amp-Activated Protein Kinase Activity During Cellular Senescence Linked To Reduced Hur Function

Autophagy protects against senescence and apoptosis via the RAS-mitochondria in high-glucose-induced endothelial cells.

Autophagy through 4EBP1 and AMPK regulates oxidative stress-induced premature senescence in auditory cells

Role of AMPK mediated pathways in autophagy and aging

mTOR Activity and Autophagy in Senescent Cells, a Complex Partnership

Autophagy inhibits the mesenchymal stem cell aging induced by D-galactose through ROS/JNK/p38 signalling

Autophagic Flux Restoration of Senescent T Cells Improves Antitumor Activity of TCR‐engineered T Cells

Autophagosomes Increased in H2O2-induced Premature Senescent 2BS Cells

Autophagy impairment with lysosomal and mitochondrial dysfunction is an important characteristic of oxidative stress-induced senescence

Apoptotic transition of senescent cells accompanied with mitochondrial hyper-function.

Autolysosomal degradation of cytosolic chromatin fragments antagonizes oxidative stress-induced senescence

Autophagy facilitates oncogene-induced senescence

Dihydroartemisinin eliminates senescent cells by promoting autophagy‐dependent ferroptosis via AMPK/mTOR signaling pathway

Decreased autophagy and fuel switching occur in a senescent hepatic cell model system

PDK4-dependent hypercatabolism and lactate production of senescent cells promotes cancer malignancy

Mitochondrial peptides modulate mitochondrial function during cellular senescence

The mTORC1-autophagy pathway is a target for senescent cell elimination